January 30, 2023 03:41 PM EST
Pharma
Law

As­traZeneca, No­vo Nordisk and Sanofi score 340B-re­lat­ed ap­peals court win over HHS

Zachary Brennan

Senior Editor

As­traZeneca, No­vo Nordisk, and Sanofi won an ap­peals court win on Mon­day, as the US Court of Ap­peals for the Third Cir­cuit found that the …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

VP, Clinical Development / CMO / CDO‬ ‭ (Stealth Portfolio Company)

Autonomy Bio Inc.

San Francisco, CA 94107, USA

TRENDING NOW

Chi­na start­up in­jects CRISPR ther­a­py in­to the brain for the first time

Makary, in one of first com­ments on FDA pol­i­cy, floats new path­way for rare dis­ease drugs

Roivant brings rare dis­ease pro­gram clos­er as Im­muno­vant CEO re­tires

Trodelvy and Keytru­da com­bo suc­ceeds in Phase 3 breast can­cer study

FDA ap­proves Dupix­ent for hives, re­jects new Eylea dos­ing sched­ule

sponsored

AD­STI­LADRIN® (nad­o­fara­gene fi­rade­n­ovec-vncg) – A Grow­ing Body of Clin­i­cal Da­ta and Re­al-World Ev­i­dence

A service from the Financial Times